Blog

An excellent team of outstanding neurosurgeons at Pacific Neuroscience Institute’s Brain Tumor Center has reported on 129 minimally invasive supraorbital (SO) surgeries in a recent paper; the highly encouraging results of a retrospective study are discussed. Minimally Invasive Surgery for Removal of Brain and Skull...

Neurodegenerative disease is a broad term for a range of conditions which mostly affect neurons in the human brain. Currently, 5 million Americans suffer from Alzheimer's disease; 1 million from Parkinson's disease; and 30,000 from Huntington's disease.

A recently published paper by Pacific Neuroscience Institute researchers suggests a promising new approach for a biopsy-free method to identify primary brain tumor genetics for personalized treatment options.

Nanotechnology is a compelling new drug delivery method in oncology where nanoparticles are engineered to target therapeutics to kill cancer. Find out more in Dr. Venkata Yenugonda's review article in the March 2019 issue International Journal of Nanomedicine.

More than 25 percent of women with Cushing’s disease experienced their first symptoms within one year of giving birth, a small study by researchers at Pacific Neuroscience Institute found.

Keeping Cerebrospinal Fluid Leaks and Meningitis at Bay. Defining the optimal exit strategy in pituitary and skull base tumor surgery, PNI authors have published a landmark article in the May 2018 issue of Journal of Neurosurgery. Leading the way in the field of minimally invasive surgery, PNI’s expert team reported on intraoperative repair of skull base defects and prevention of post-operative CSF leaks and meningitis in over 500 patients with pituitary tumors and skull base tumors.

Read Pacific Neuroscience Institute's latest article about gravity-assisted brain surgery published in the December 2017 issue of Operative Neurosurgery. Cover artwork for the journal created by medical illustrator Josh Emerson.